Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meetingBoris Jülg, Bruce D. Walker, Krista L. Dong et al.|The Lancet HIV|2019Cited by 206
Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunityJulia Niessl, Daniel E. Kaufmann, Amy E. Baxter et al.|Nature Medicine|2020Cited by 164
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 studyYehuda Z. Cohen, Marina Caskey, Allison L. Butler et al.|PLoS ONE|2019Cited by 92
A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controlsJames McMahon, Sharon R. Lewin, Jennifer M. Zerbato et al.|EBioMedicine|2021Cited by 21